GERALD MARTIN: Open Payments
NPI 1770014748 · CARBONDALE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$821 in 36 payments from 9 companies in 2025. Trend: 2023 $377 · 2024 $485 · 2025 $821
Food & beverage: $821
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 8 | $167 |
| Otsuka America Pharmaceutical, Inc. | 5 | $130 |
| Neurocrine BioSciences, Inc. | 6 | $129 |
| Lundbeck LLC | 5 | $124 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $98 |
| Alkermes, Inc. | 4 | $92 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $45 |
| Axsome Therapeutics, Inc. | 1 | $20 |
| ABBVIE INC. | 1 | $17 |
Products named: REXULTI, INGREZZA, SPRAVATO, CAPLYTA, ARISTADA, INVEGA SUSTENNA, TRINTELLIX, Auvelity.
Industry payments across IL — which companies pay providers there.
